The ROE (Return on Equity) of Medite Cancer Diagnostics Inc (MDIT) is -117.94%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2017-12-31 | -117.94% |
| 2016-12-31 | -26.96% |
| 2015-12-31 | -9.37% |
| 2014-12-31 | -8.29% |
| 2013-12-31 | 2.06% |
| 2012-12-31 | 20.82% |
| 2011-12-31 | 46.68% |
| 2010-12-31 | 56.15% |
| 2009-12-31 | 167.45% |
| 2008-12-31 | -1582.50% |